Header Logo

Connection

Mark Pollack to Administration, Oral

This is a "connection" page, showing publications Mark Pollack has written about Administration, Oral.
Connection Strength

0.100
  1. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42.
    View in: PubMed
    Score: 0.074
  2. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6.
    View in: PubMed
    Score: 0.006
  3. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990; 24(2):177-84.
    View in: PubMed
    Score: 0.006
  4. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6.
    View in: PubMed
    Score: 0.005
  5. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94.
    View in: PubMed
    Score: 0.005
  6. Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.